BR

BrightPath Biotherapeutics Co., Ltd.

Developing novel cancer immunotherapies, including peptide vaccines and iPS-NKT cell therapies.

4594 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
川崎市川崎区殿町三丁目25番22号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

BrightPath Biotherapeutics is a clinical-stage biopharmaceutical company specializing in the development of novel cancer immunotherapies. The company's pipeline encompasses multiple platforms, including cancer peptide vaccines, immuno-modulators, and advanced cell therapies. A primary focus is its proprietary iPS-NKT platform, a novel allogeneic cell therapy that uses natural killer T-cells (NKT cells) derived from induced pluripotent stem cells (iPSCs) for cancer treatment. This technology enables the large-scale, homogeneous production of NKT cells, which are naturally rare. The company, formerly known as GreenPeptide, also develops peptide vaccines like GRN-1201, which has progressed to clinical trials. Its business model covers drug discovery, research, and early-phase clinical development.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-20 09:01
Post-Annual General Meeting Information
臨時報告書
Japanese 22.8 KB
2025-06-19 08:36
Registration Form
確認書
Japanese 8.9 KB
2025-06-19 08:32
Governance Information
内部統制報告書-第22期(2024/04/01-2025/03/31)
Japanese 23.4 KB
2025-06-19 08:25
Registration Form
有価証券報告書-第22期(2024/04/01-2025/03/31)
Japanese 933.5 KB
2024-11-08 07:35
Interim Report
確認書
Japanese 9.0 KB
2024-11-08 07:34
Interim Report
半期報告書-第22期(2024/04/01-2025/03/31)
Japanese 224.9 KB
2024-06-21 09:07
Regulatory News Service
訂正有価証券届出書(組込方式)
Japanese 254.0 KB
2024-06-21 08:34
Regulatory News Service
内部統制報告書-第21期(2023/04/01-2024/03/31)
Japanese 23.2 KB
2024-06-21 08:33
Registration Form
確認書
Japanese 9.0 KB
2024-06-21 08:32
Annual Report
有価証券報告書-第21期(2023/04/01-2024/03/31)
Japanese 990.5 KB
2024-06-19 08:00
Registration Form
有価証券届出書(組込方式)
Japanese 513.9 KB
2024-02-09 07:12
Report Publication Announcement
確認書
Japanese 9.1 KB
2024-02-09 07:11
Quarterly Report
四半期報告書-第21期第3四半期(2023/10/01-2023/12/31)
Japanese 195.3 KB
2023-11-15 07:27
Registration Form
訂正有価証券届出書(組込方式)
Japanese 183.0 KB
2023-11-14 07:56
Registration Form
有価証券届出書(組込方式)
Japanese 332.0 KB

Automate Your Workflow. Get a real-time feed of all BrightPath Biotherapeutics Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for BrightPath Biotherapeutics Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France ALACT
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland ADI1
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea 397810
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany APM

Talk to a Data Expert

Have a question? We'll get back to you promptly.